Literature DB >> 15636616

Enhanced donor-specific alloreactivity occurs independently of immunosuppression in children with early liver rejection.

Rakesh Sindhi1, Amy Magill, Carol Bentlejewski, Ali Abdullah, Mary Tresgaskes, Joseph Seward, Janine Janosky, Adriana Zeevi.   

Abstract

UNLABELLED: To determine whether early acute cellular rejection (ACR) is associated with sub-optimal immunosuppression in children with liver transplants (LTx).
METHODS: Twenty-five children with primary LTx after pre-transplant rabbit anti-thymocyte globulin (rATG), and steroid-free tacrolimus (TAC) were evaluated. Mitogen-stimulated T- and B-cell responses and mixed lymphocyte response to donor and third-party antigens were performed at several time points between two consecutive TAC doses. TAC concentrations (C) associated with half-maximal effect (EC(50)) on lymphocytes was determined by pharmacodynamic equations.
RESULTS: Mean age was 7.2 +/- 6.2 years, mean time to lymphocyte function studies was 25 +/- 19 days. Acute rejection occurred at a mean interval of 31 +/- 19 days after LTx. Rejectors (n = 16) demonstrated significantly higher EC(50) of TAC for the intra-cellular IFN-gamma in T cells (p = 0.005) and its CD8+ sub-population (p = 0.027) as well as the co-stimulatory/activation receptor CD54 on B cells (p = 0.0001). The response of recipient lymphocytes to donor antigen was significantly higher in rejectors, compared with non-rejectors (p = 0.015). The patient groups demonstrated no differences in third-party MLR, or in C of TAC.
CONCLUSIONS: Independent of the amount of immunosuppressant, ACR of liver allografts in children is associated with enhanced donor-specific alloreactivity. This is accompanied by a cytotoxic T-cell sub-population with increased requirement for TAC.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15636616     DOI: 10.1111/j.1600-6143.2004.00639.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  9 in total

Review 1.  Immune monitoring post liver transplant.

Authors:  Siddharth Sood; Adam G Testro
Journal:  World J Transplant       Date:  2014-03-24

2.  Predicting Cellular Rejection With a Cell-Based Assay: Preclinical Evaluation in Children.

Authors:  Chethan Ashokkumar; Kyle Soltys; George Mazariegos; Geoffrey Bond; Brandon W Higgs; Mylarappa Ningappa; Qing Sun; Amanda Brown; Jaimie White; Samantha Levy; Tamara Fazzolare; Lisa Remaley; Katie Dirling; Patricia Harris; Tara Hartle; Pamela Kachmar; Megan Nicely; Lindsay OʼToole; Brittany Boehm; Nicole Jativa; Paula Stanley; Ronald Jaffe; Sarangarajan Ranganathan; Adriana Zeevi; Rakesh Sindhi
Journal:  Transplantation       Date:  2017-01       Impact factor: 4.939

3.  Elevated myeloid: plasmacytoid dendritic cell ratio associates with late, but not early, liver rejection in children induced with rabbit anti-human thymocyte globulin.

Authors:  Ankit Gupta; Chethan Ashok Kumar; Mylarappa Ningappa; Qing Sun; Brandon W Higgs; Sara Snyder; Adriana Zeevi; Angus W Thomson; George V Mazariegos; Rakesh Sindhi
Journal:  Transplantation       Date:  2009-08-27       Impact factor: 4.939

4.  Proliferative alloresponse of T-cytotoxic cells identifies rejection-prone children with steroid-free liver transplantation.

Authors:  Chethan Ashokkumar; Qing Sun; Ankit Gupta; Brandon W Higgs; Tamara Fazzolare; Lisa Remaley; George Mazariegos; Kyle Soltys; Geoffrey Bond; Rakesh Sindhi
Journal:  Liver Transpl       Date:  2009-08       Impact factor: 5.799

5.  Genetic variants in major histocompatibility complex-linked genes associate with pediatric liver transplant rejection.

Authors:  Rakesh Sindhi; Brandon W Higgs; Daniel E Weeks; Chethan Ashokkumar; Ronald Jaffe; Cecilia Kim; Patrick Wilson; Nydia Chien; Joseph Glessner; Anjan Talukdar; George Mazariegos; M Michael Barmada; Edward Frackleton; Nancy Petro; Andrew Eckert; Hakon Hakonarson; Robert Ferrell
Journal:  Gastroenterology       Date:  2008-06-03       Impact factor: 22.682

6.  Allospecific CD154+ T cells associate with rejection risk after pediatric liver transplantation.

Authors:  C Ashokkumar; A Talukdar; Q Sun; B W Higgs; J Janosky; P Wilson; G Mazariegos; R Jaffe; A Demetris; J Dobberstein; K Soltys; G Bond; A W Thomson; A Zeevi; R Sindhi
Journal:  Am J Transplant       Date:  2008-10-31       Impact factor: 8.086

7.  Lymphocyte subset reconstitution in pediatric liver recipients induced with steroid-free rabbit anti-human thymocyte globulin.

Authors:  Anjan Talukdar; Chethan AshokKumar; Jennifer Farrar; Patrick Wilson; Arun Janakiramanan; Mary Tregaskes; Rakesh Sindhi
Journal:  Pediatr Transplant       Date:  2008-11

8.  Profile of the Pleximmune blood test for transplant rejection risk prediction.

Authors:  Rakesh Sindhi; Chethan Ashokkumar; Brandon W Higgs; Samantha Levy; Kyle Soltys; Geoffrey Bond; George Mazariegos; Sarangarajan Ranganathan; Adriana Zeevi
Journal:  Expert Rev Mol Diagn       Date:  2016-02-16       Impact factor: 5.225

9.  Alloreactive CD154-expressing T-cell subsets with differential sensitivity to the immunosuppressant, belatacept: potential targets of novel belatacept-based regimens.

Authors:  Chethan Ashokkumar; Bishu Ganguly; Robert Townsend; Jaimie White; Samantha Levy; Michael Moritz; George Mazariegos; Qing Sun; Rakesh Sindhi
Journal:  Sci Rep       Date:  2015-10-16       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.